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The chromosome 1q21.1 duplication syndrome (OMIM# 612475) is characterized by
head anomalies, mild facial dysmorphisms, and cognitive problems, including autistic
features, mental retardation, developmental delay, and learning disabilities. Speech and
language development are sometimes impaired, but no detailed characterization of
language problems in this condition has been provided to date. We report in detail
on the cognitive and language phenotype of a child who presents with a duplication
in 1q21.1 (arr[hg19] 1q21.1q21.2(145,764,455-147,824,207)×3), and who exhibits
cognitive delay and behavioral disturbances. Language is significantly perturbed, being
the expressive domain the most impaired area (with significant dysphemic features in
absence of pure motor speech deficits), although language comprehension and use
(pragmatics) are also affected. Among the genes found duplicated in the child, CDH1L is
upregulated in the blood of the proband. ROBO1, a candidate for dyslexia, is also highly
upregulated, whereas, TLE3, a target of FOXP2, is significantly downregulated. These
changes might explain language, and particularly speech dysfunction in the proband.
Keywords: chromosome 1q21.1 duplication syndrome, cognitive delay, language deficits, speech problems,
CDH1L, ROBO1
INTRODUCTION
Copy number variant (CNV) syndromes entailing language impairment provide important
evidence of how changes in gene dosage impact on the wiring and function of brain areas
involved in language processing. The 1q21.1 region contains several segmental-duplication blocks
which favor the occurrence of microdeletions and microduplications. The chromosome 1q21.1
duplication syndrome (OMIM# 612475) results from microduplications of the BP3-BP4 region,
with a minimum duplicated region of ∼1.2Mb of unique DNA sequence, which includes at least
seven genes, although a less common variant, resulting from microduplications of the BP2-BP4
region, with a duplicated region of ∼2Mb and encompassing the region deleted in the TAR
syndrome (OMIM# 274000), has been also reported (1). These two variants are commonly referred
as Class I 1q21.1 duplication syndrome and Class II 1q21.1 duplication syndrome, respectively.
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Many of the subjects bearing the 1q21.1 microduplication
exhibit autistic features, attention deficit-hyperactivity disorder,
mild or moderate mental retardation, relative macrocephaly,
mild dysmorphic features, heart disease, and hypotonia
(1–3). Some of these features are shared with carriers of
the reciprocal deletion, including cognitive dysfunction,
motor problems, articulation deficits, and hypotonia (4).
Interestingly, microcephaly is prevalent in deletion carriers,
whereas macrocephaly is common in duplication carriers;
likewise, deletions are usually associated with schizophrenia,
while carriers of the duplication usually exhibit autistic
features [(4) and references herein]. Interestingly too, the adult
phenotype seems to be milder than the child presentation of the
syndrome and includes macrocephaly and abnormalities
of possible connective tissue origin, and occasionally,
schizophrenia (3). Overall, because the microduplication
(as well as the reciprocal deletion) is associated with a highly
variable phenotype, and because it exhibits an incomplete
penetrance and variable expressivity, it has been suggested
that this is a susceptibility locus, rather than a clinically
distinct syndrome, which predisposes to neurodevelopmental
problems (5).
Little is known about the genetic causes of the
neuropsychiatric phenotype of 1q21.1 duplications. The
distinctive genomic architecture of the 1q21.1 region, which
accounts for its genomic instability, seems to be evolutionarily
advantageous, and includes multiple human-specific changes
(compared to extant primates) important for brain evolution,
such as the expansion of genes coding for proteins with
DUF1220 protein motifs, and the duplicative transpositions of
non-1q21.1 genes, like SRGAP2 and HYDIN (6). According to
Dolcetti et al. (3), gene expression data suggest that candidate
genes for the distinctive cognitive profile of people with the
1q21.1 microduplication may include BCL9, GJA8, PDZK1,
and PRKAB2. Nonetheless, no conclusive genotype-phenotype
correlations have been found. This is particularly true of the
language problems that are commonly observed in patients,
among other reasons, because we still lack a comprehensive
characterization of the language phenotype associated to this
condition.
In this paper, we report on a boy with a microduplication
of the 1q21.1 region and provide a detailed description of his
language (dis)abilities. Relying on our current knowledge of the
genetic aspects of language development and language evolution,
but also on ad-hoc analyses of the expression pattern of selected
genes in the blood of our proband, we propose BCL9 and
CDH1L as principal candidates for language dysfunction in this
syndrome.
MATERIAL AND METHODS
Linguistic, Cognitive, and behavioral
Assessment
The global developmental profile of the proband was evaluated
with the Spanish versions of the Battelle Developmental
Inventories (7), the Luria-Nebraska Neuropsychological Battery
for Children (LNNB-C) (8), the Kaufman Assessment Battery for
Children (K-ABC) (9), and the Inventory for Client and
Agency Planning (ICAP) (10). The Spanish version of the
Autism Diagnostic Observation Schedule- Revised (ADOS-R)
was used, specifically, for screening autistic features in the
child.
Battelle Developmental Inventories
Battelle Developmental Inventories consist of 341 items and
are aimed to evaluate personal/social development, adaptive
capabilities, motor abilities (gross and fine), communication
skills (in the receptive and expressive domains), and cognitive
development.
Luria-Nebraska Neuropsychological Battery for
Children (LNNB-C)
The LNNB-C is aimed to evaluate (and anticipate) the child’s
learning, experience, and cognitive skills, as well as his
neuropsychological deficiencies. The test comprises 10 scales that
are aimed to measure executive functioning in several areas of
interest (manual mobility, left-right orientation, gestures and
praxias, verbal regulation, spatial orientation) as well as language
functioning in different domains (object and drawing naming,
phonological awareness, vocabulary in pictures, similarities and
dissimilarities, and numerical operations).
Kaufman Assessment Battery for Children (K-ABC)
The K-ABC is aimed to evaluate diverse processing and cognitive
abilities as they are put into use, either simultaneously or
sequentially, to resolve specific problems. The test comprises
16 subtests arranged into three scales: Simultaneous Processing,
Sequential Processing, and Knowledge.
Inventory for Client and Agency Planning (ICAP)
The ICAP is aimed to evaluate the subject’s functional abilities
and maladaptive behaviors in the following general areas:
motor skills, social and communication skills, personal living
skills, and community living skills. The ICAP measures the
frequency and severity of eight types of behavioral disturbances,
which are organized in three subscales: asocial maladaptive
behavior (uncooperative behavior and socially offensive
behavior), internalized maladaptive behavior (withdrawn or
inattentive behavior, unusual or repetitive habits, and self-harm),
and externalized maladaptive behavior (disruptive behavior,
destructive to property, and hurtful to others). Behavior is
rated as normal or abnormal, whereas behavioral problems are
subsequently rated as marginally serious, moderately serious,
serious, or very serious.
Autism Diagnostic Observation Schedule-Revised
(ADOS-R)
This test is designed for toddlers between 18 and 60 months
and comprises 23 questions. A positive score is indicative of the
possibility of suffering from the disease.
Regarding the language profile of the child, his abilities were
evaluated in detail with the Prueba de Lenguaje Oral de Navarra-
Revisada [Navarra Oral Language Test, Revised] (PLON-R) (11),
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and the Spanish version of the Peabody Picture Vocabulary Test,
Third Edition [PPVT-3; (12)].
Prueba de Lenguaje Oral de Navarra-Revisada
(PLON-R)
This test was used to assess in depth the child’s expressive abilities.
The PLON-R is aimed for children between 3 and 6 years,
and characterizes language production both structurally and
functionally. The composite score “form” evaluates speech sound
production at the level of single word, phonological awareness,
as well as morphological and syntactic features of the child’s
imitated and elicited verbal production. The composite score
“contents” assesses word and sentence meanings. Finally, the
test also evaluates different aspects of language use (planning,
autoregulation, and modification under environmental cues) in
semi-spontaneous conditions.
Peabody Picture Vocabulary Test (PPVT-3)
This test was used to evaluate in more detail the receptive abilities
of the proband. The PPVT-3 assesses the correct acquisition of
words by the child via several tasks in which the child is asked to
point to one of four color pictures on a page after hearing a word.
Additionally, language in use and overall communication
skills in spontaneous conditions were assessed through the
systematic analysis of a 17-min sample of the child’s talk
in interaction with his mother. The conversation was video-
recorded and then transcribed and coded using CHAT (Codes
for the Human Analysis of Transcripts) software, a tool
of the CHILDES Project (13). CHAT allows to code for
speech production phenomena (including information about
articulation, prosody, and fluency) in the main lines of the
transcript, and for phonological, morphological, syntactic and
pragmatic phenomena in dependent lines.
It has to be pointed out that, when evaluating language
in use, every linguistic phenomenon is to be assessed from a
pragmatic perspective (14). Thus, we first tagged the linguistic
errors made by the child indicating the linguistic components
affected (phonology, morphology, syntax, lexical semantics).
Then we evaluated the communicative effects of each error
and labelled it accordingly on the pragmatic level, using the
Pragmatic Evaluation Protocol for the analysis of oral Corpora
(PREP-CORP), which has been satisfactorily used to provide
the linguistic profile of other neurogenic disorders (15–17).
The number of occurrences of each labeled phenomenon was
automatically computed by means of CLAN (Computerized
Language Analysis) (18), allowing us to build up a global
description of the pragmatic linguistic profile of the proband, that
is to say, of the most salient phenomena of his language in use.
Finally, the linguistic profile of the proband’s parents was
assessed with the verbal scale of the Spanish version of theWAIS-
III (19), the Test de Aptitud Verbal “Buenos Aires” [Buenos
Aires Verbal Aptitude Test] (BAIRES) (20), the Batería para la
Evaluación de los Procesos Lectores en Secundaria y Bachillerato
[Battery for the evaluation of reading abilities in high school
students] (PROLEC-SE) (21), and one specific task aimed to
evaluate the comprehension of passives and correferences.
WAIS-III
The verbal scale of the WAIS-III comprises six tasks aimed to
assess the subject’s abilities in two different domains of language
processing: verbal comprehension [Similarities (S), Vocabulary
(V), Information (I), and Comprehension (CO)] and working
memory [Digits (D) and Arithmetic (A)].
BAIRES
The BAIRES is aimed to evaluate language comprehension and
production in subjects above 16 years old. It comprises two tasks
which assesses the subject’s ability to understand and provide
with synonymic words and verbal definitions, respectively.
PROLEC-SE
The PROLEC-SE is aimed to assess the reading abilities by
adolescents between 12 and 18 years old. It comprises six tasks
which evaluate three different processes involved in reading:
lexical (word reading, pseudoword reading), semantic (text
comprehension, text structure), and syntactic (picture-sentence
mapping, punctuation marks).
Ad-hoc task
The ad-hoc task was a sentence-picture-matching task aimed
to evaluate the comprehension of bound anaphora in complex
sentences (that is, the ability to properly bind a determiner phrase
in the subordinated clause to a referential element in the main
clause) and of canonical long passive structures (that is, with a by-
phrase). While the former task enquires about highly-demanding
computational abilities in the domain of language processing, the
latter is usually difficult for people with poor reading abilities,
because in Spanish passives are much more frequent in the
literary register.
Molecular and cytogenetic Analysis
DNA from the patient and his parents was extracted from 100 µl
of EDTA-anticoagulated whole blood using MagNA Pure (Roche
Diagnostics, West Sussex, UK) and used for subsequent analyses.
Karyotype Analysis
Peripheral venous blood lymphocytes were grown following
standard protocols and collected after 72 h. A moderate
resolution G-banding (550 bands) karyotyping by trypsin (Gibco
1x trypsin R© and Leishmann stain) was subsequently performed.
Microscopic analysis was performed with a Nikon R© eclipse
50i optical microscope and the IKAROS Karyotyping System
(MetaSystem R© software).
Fragile X Syndrome Analysis
CGG expansions affecting the gene FMR1 (the main determinant
for Fragile X syndrome) were analyzed in the patient according
to standard protocols. Polymerase chain reaction (PCR) of the
fragile site was performed with specific primers for the fragile
region of the FMR1 locus and the trinucleotide repeat size of the
resulting fragments was evaluated by electrophoresis in agarose
gel.
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Multiplex Ligation-Dependent Probe Amplification
(MLPA)
MLPA was performed to detect abnormal CNV of the
subtelomeric regions of the probands’ chromosomes. MLPA is
based on the amplification (by use of a single PCR primer
pair) of many different probes, each of which detecting a
specific subtelomeric DNA sequence. Three different kits from
MRC-Holland were used: SALSA R© MLPA R© probemix P036-E3
SUBTELOMERES MIX 1, SALSA R© MLPA R© probemix P070-
B3 SUBTELOMERES MIX 2B, and SALSA R© MLPA R© probemix
P245-B1 Microdeletion Syndromes-1A. The PCR products were
analyzed by capillary electrophoresis in an automatic sequencer
Hitachi 3500 and further analyzed with the Coffalyser V 1.0
software from MRC-Holland.
Microrrays for CNVs Search and Chromosome
Aberrations Analysis
The DNA from the patient and his parents was hybridized on
a CGH platform (Agilent Technologies). The derivative log ratio
spread (DLRS) value was 0.172204. The platform included 60.000
probes. Data were analyzed with Agilent CytoGenomics 3.0.5.1
and qGenViewer, and the ADM-2 algorithm (threshold= 6.0; abs
(log2ratio)= 0.25; aberrant regions had more than 4 consecutive
probes).
qPCR
The expression pattern of genes of interest was assessed in blood
by qRT-PCR in order to determine possible differences between
the proband and his parents. Total RNA extraction and qRT-
PCR were done as previously described (22). Briefly, total RNA
was extracted from cells using Trizol (Sigma Aldrich) according
to the manufacturer’s procedure, followed by a treatment with
RNase-free DNase (Roche). cDNA was synthesized from 1 µg of
total RNA using a Superscript III First Strand cDNA synthesis kit
(LifeTechnologies). Amounts of specific mRNAs in samples were
quantified by qRT-PCR using an ABIPrism 7900 HT Detection
System (Applied Biosystems) and SYBR green detection. PCR
was performed in 96-well microtest plates (Applied Biosystems)
with 0.5 units of Taq Polymerase (Applied Biosystems) per well
and 35–40 cycles. In all experiments, mRNA amounts were
normalized to the total amount of cDNA by using amplification
signals for hGUSB. Each sample was determined in triplicate,
and at least three independent samples of each patient were
analyzed. Primer sequences and PCR conditions are listed in
Supplementary Table 1.
Ethics approval for this research was granted by the Comité
Ético del Hospital “Reina Sofía.” Written informed consent was
obtained from the proband’s parents for publication of this case
report and of any accompanying tables and images.
RESULTS
Clinical History
The proband (Figure 1A) is a boy born by normal delivery
after 37 weeks of risk gestation because of placenta previa with
bleeding and threatened abortion. The mother was a 28-year-
old woman, who suffered from high blood pressure and diabetes
mellitus during pregnancy and who consumed anxiolytic drugs
during the first trimester. At the delivery, no signs of disease
were observed in the newborn. The child suffered from recurrent
infantile colic during the first months of life, as well as from
irritability that seriously disturbed his sleeping. At age 2 years
and 3 months, his weight was 9.490 kg (percentile 1), his height
86.5 cm (percentile 18) and the occipitofrontal circumference
41.2 cm (below percentile 1). At present, when he is 6 years
old, his weight is 19 kg (percentile 21), his height 117 cm
(percentile 62) and the occipitofrontal circumference 50 cm
(around percentile 30). Cranial magnetic resonance imaging
(MRI), performed at 5 years and 7 months of age, yielded
normal results. The child was set twice a tympanic drainage in
conjunction with adenoidectomy (at 3 years and 4 years). At that
time, the Eustachian tube was reported to be underdeveloped,
although no auditory impairment was observed. One paternal
cousin of the proband is dyslexic, whereas a second paternal
cousin (from a different brother of the father) suffers from
language developmental delay. Finally, the child exhibits facial
dysmorphisms, including mild hypertelorism, small nose, and
protruding ears.
Language and Cognitive Development
Developmental anomalies were first reported by the teachers of
the nursery school when the proband was 2 years old. The child
was unable to stand up without aid and fine and gross motor
abilities seemed severely delayed. Bladder and bowel control had
not been achieved either. The child only babbled and no single
word was observed. Stereotypic behavior was reported. The child
received early childhood intervention from age 2 years and 4
months. At age 2 years and 8 months his global development
was assessed in detail with the Spanish version of the Battelle
Developmental Inventories. The resulting scores were suggestive
of a mild developmental delay, mostly impacting on his language,
social and adaptive abilities, whereas his cognitive skills were
slightly above the mean (Figure 1B). When he was 3 years old,
the boy started attending a normal nursery school.
At age 5, the parents reported a generalized cognitive and
behavioral regression. Stereotypic behaviors increased and the
child exhibited lack of cognitive flexibility, occasional spatial
disorientation, obsessive behavior, perseverations, unmotivated
fears to darkness or load sounds, and lack of interaction with
his peers at school. Although he seemed to have mastered a good
vocabulary, he failed to put it into use for normal interaction. He
also had problems with the conceptualization of time. Moreover,
although he received speech and cognitive aid and therapy on a
daily basis, at school he failed in achieving the learning objectives
planned for that age.
At age 5 years and 4 months, the Spanish version of the
Battelle Developmental Inventories was administered again.
The obtained scores were not suggestive of a generalized
regression, although the child’s cognitive skills seemed more
impaired than at younger ages (Figure 1B). The Spanish
version of the Kaufman Assessment Battery for Children was
also administered to evaluate his learning abilities. The most
impaired areas were the general mental processing abilities
(very significant deficit) and the sequential processing abilities
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FIGURE 1 | Main physical and cognitive findings in the proband. (A) Facial picture illustrating some of the dysmorphological features found in the proband. Written
informed consent was obtained from the parents of the child for the publication of this image. (B) Developmental profiles of the proband at 2 years and 8 months (blue)
and at 5 years and 4 months (orange) according to the Battelle Developmental Inventories. In order to make more reliable comparisons, the resulting scores are shown
as relative values referred to the expected scores according to the chronological age of the child. DA, developmental age; CA, chronological age. (C) Developmental
profile of the proband at age 5 years and 6 months according to Luria-Nebraska Neuropsychological Battery for Children (LNNB-C). DA, developmental age; CA,
chronological age. (D) Developmental profile of the proband at age 5 years and 6 months according to the Inventory for Client and Agency Planning (ICAP).
(significant deficit), although the child scored lower than his
peers in the remaining domains too. These results reinforce the
view that the widespread regression reported by the parents
was not for real, and that the child’s poor performance in
daily tasks, which becomes more evident as the boy grows
older, might result from a moderate learning deficit caused
by his linguistic and cognitive deficits. Additionally, in view
of the behavioral problems reported by parents and teachers,
but also of the scores obtained in the Batelle Developmental
Inventories, the Spanish version of the Autism Diagnostic
Observation Schedule- Revised (ADOS-R) was administered at
the age of 5 years and 5 months. The child did not fulfill
the requirements for Autism Spectrum Disorders (ASDs). He
scored normally in all the tasks, including the use of non-
verbal aspects of social interaction, interactive symbolic play,
reciprocity during interaction and play, and understanding of,
and response to, others’ beliefs. The boy usually paid attention
to others and was able to express his own feelings toward them
and about himself. What is more, the qualitative analysis of
the interactive aspects of the spontaneous conversation with
his mother confirmed the absence of autism. In truth, the
autistic-like behaviors initially reported by parents and teachers
(avoidance behaviors, obsessive behaviors, lack of visual contact)
were mostly observed when the child was placed in an unfamiliar
environment and felt stressed, unsecure, or anxious. It is also
possible that he suffered from some sort of compulsive-obsessive
disorder.
When the child was 5 years and 6 months old, his global
linguistic and cognitive profile, as well as his learning abilities
were also evaluated with the Luria-Nebraska Neuropsychological
Battery for Children (LNNB-C). The obtained scores were
suggestive of a deep impairment of language and executive
functions (in all the assessed domains the scores corresponded to
percentiles 1–2) (Figure 1C). Likewise, the Inventory for Client
and Agency Planning (ICAP) was administered for assessing
the child’s adaptive behavior. The obtained scores (Figure 1D)
were indicative of a delay of nearly 2 years in his global
development, being social and communication skills the most
impaired domain.
Because of the significant impairment and delay observed in
the language domain, we also evaluated in detail the linguistic
abilities of the proband at the age of 5 years and 6 months. The
global score obtained in the Prueba de Lenguaje Oral de Navarra-
Revisada (PLON-R), which evaluates speech sound production at
the single word level as well as expressive abilities, was suggestive
of a mild delay in the acquisition of the expressive component
of language, being phonological awareness and morpho-syntax
the most impaired domains. Likewise, a mild delay was suggested
regarding the use of language. On the contrary, the child
scored like their peers regarding the meaning of words and
sentences. Concerning his receptive abilities in the domain of
language, the global score obtained in the Spanish version of
the Peabody Picture Vocabulary Test (PPVT-3) was suggestive
of a delay of 12 months in the acquisition of the meaning of
words, with an expected negative impact of his comprehension
abilities.
Lastly, we examined in detail the child’s language in use
and his communication skills through the analysis of a
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naturally-occurring interaction with his mother. The proband’s
speech production abilities in natural settings were severely
impaired, hindering the child’s intelligibility and communication
success. Fluency problems included syllabified and effortful
articulation, reduplication of syllables in any position of the
word, and severe alterations of rhythm, use of pauses, volume,
and prosody. Assimilation of specific sounds was frequent
in the boy’s speech, as well as simplifications of consonant
clusters and deletions of weak syllables. Omissions of strong
syllables (those bearing the primary stress) and of sounds in
initial position were occasionally observed too. Concerning
language structure and complexity, the child’s mean length of
utterance in words (MLUw) was 2.6, which is within the range
observed in children aged between 2 years and 6 months,
and 2 years and 11 months (23), and thus remarkably lower
than the expected value by age. In longer utterances, the
child produced morpho-syntactic errors, such as additions or
substitutions of prepositions, or omissions of weak pronouns
(usually, personal pronouns functioning as the object of the
sentence [me “me” vs. yo “I”]), which may be due to the
widespread weak-syllable deletions observed in his discourse.
Finally, his interactive pragmatic skills seemed to be preserved:
visual contact and joint attention mechanisms were normal, as
well as patterns of turn taking and construction of collaborative
turns during conversation. However, enunciative pragmatic
skills (that is, principles of language use regulating how
utterances are interpreted in their contexts of usage), such as
the observation of maxims of quality (“be truthful and do
not give information that is false or that is not supported by
evidence”) and relation (“be relevant, and say things that are
pertinent to the discussion”) (24), were slightly impaired, which
might be related to his attention problems and/or intellectual
disability.
Cytogenetic and Molecular Analyses
Routine cytogenetic and molecular analyses of the proband were
performedwhen hewas 2 years and 7months old. PCR analysis of
the FMR1 fragile site was normal. MLPA of subtelomeric regions
was normal too. A comparative genomic hybridization array
(array-CGH) identified a duplication of 2.1Mb in the 1q21.1
region (arr[hg19] 1q21.1-q21.2(145,764,455-147,824,207)×3)
(Figure 2A). The duplicated region corresponds to the region
duplicated in Class II 1q21.1 duplication syndrome and includes
38 genes of which 13 are protein-coding genes (Figure 2B).
As noted, our proband exhibits most of the physical,
behavioral, and cognitive features of the 1q21.1 microduplication
syndrome (Table 1). The duplication was inherited from the
proband’s non-symptomatic mother (Figure 3A). The woman
exhibited a verbal IQ slightly above the mean, although with
peaks and valleys, which are suggestive of relative strengths in
the domain of attention and auditory memory (task Digits)
and of relative weaknesses in the domain of symbol processing
(task Arithmetic) (Figure 3B). Additionally, she exhibited a
very good command of verbal abilities as assessed by the
BAIRES test, around percentile 90th, and normal-to-high reading
abilities (Figure 3C). We have not assessed other features of the
microduplication. The fact that she suffered from anxiety during
pregnancy might be indicative of some affectedness in other
domains [see (4), Table 2], but as far as language and cognition
are concerned, she performed normally.
In order to delve into the molecular causes of the speech
and language problems exhibited by the child, we surveyed the
literature looking for other clinical cases in which language
deficits have been linked or associated to the mutation or the
dysfunction of any of the genes duplicated in our proband. We
found that CHD1L is a candidate for autism spectrum disorder
(ASD) and attention deficit hyperactivity disorder (ADHD)
(25, 26), whereas PRKAB2 and BCL9 have been associated to
schizophrenia (27–30).
We also relied on DECIPHER (https://decipher.sanger.ac.
uk/) to find cases of CNVs affecting chromosomal fragments
smaller than the region duplicated in the child, that may help
associate language dysfunctions to specific genes. We found that
patients bearing microduplications not encompassing the genes
CHD1L and BCL9 do not usually exhibit language problems.
Conversely, duplications involving CHD1L entail delayed speech
and language development. No patient bearing a duplication
affecting the BCL9 only has been found (Figure 4).
Finally, we used String 10.5 (www.string-db.org) for
examining potential functional links between the genes
duplicated in our proband and genes important for language,
in particular, known candidate genes for language disorders
[dyslexia and SLI, as compiled by (31–33)] and for language
evolution, as posited by Boeckx and Benítez-Burraco
(34, 35) [importantly, many of these genes are also related
to language dysfunction in broader cognitive disorders,
particularly, autism and schizophrenia, as discussed in (36–38)]
(Supplementary Table 2). String 10.5 predicts physical and
functional associations between proteins relying on different
sources (genomic context, high-throughput experiments,
conserved coexpression, and text mining) (39). Several proteins
were predicted to be direct interactors of some of the genes found
in the duplicated fragment: FOXO1, TP53, TSC1, for PRKAB2;
PARP1, for CHD1L, and CTNNB1, ARX, TL3, and TL2, for
BCL9 (Figure 5).
In order to check the biological reliability of these potential
links and the possibility that other robust candidates for language
dysfunction were affected in our proband, we performed qRT-
PCR analyses of selected genes using blood from the proband and
his parents. We determined the expression level of (i) protein-
coding genes located within the duplicated fragment (BCL9,
GJA8, GJA5, ACP6, PDZK1, PRKAB2, CHD1L, HYDIN2), (ii)
functional partners of the protein-coding genes located within
the duplicated fragment with a known role in cognition/language
development and/or impairment, as found in the literature and
as predicted by String 10.5 (PARP1, CTNNB1, ARX, FOXP2,
TLE2, TLE3, FOXO1, TSC1), and (iii) other strong candidates
for language disorders and language evolution, as discussed in
Boeckx and Benítez-Burraco (34, 35) (AUTS2, BAZ1B, BMP2,
CNTNAP2, DCDC2, DLX1, ELP4, FOXP1, GRIN2A, POU3F2,
ROBO1, RUNX2, SLIT2, and SOX9) (Figure 4). We found that
4 genes are significantly upregulated or downregulated in the
proband compared to his healthy parents: CHD1L, ACP6, TL3,
and ROBO1 (Figure 6 and Supplementary Table 3).
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FIGURE 2 | Chromosomal alterations found in our proband. (A) Screen capture of the array-CGH of the proband’s chromosome 1 showing the microduplication at
1q21.1. (B) Screen capture of the UCSC Genome Browser (https://genome.ucsc.edu/) showing the genes duplicated in the proband.
DISCUSSION
The widespread application of next generation sequencing
facilities to the genetic diagnosis of people with cognitive
and language disorders has resulted in a growing number of
genes and chromosomal regions associated to these conditions.
Nonetheless, in most cases, no robust genotype-to-phenotype
correlations have been found. In this paper, we have characterized
the cognitive profile of a boy bearing a microduplication in
1q21.1, with a focus on his language deficits. The boy exhibits
many of the cognitive, behavioral, and physical symptoms of
the 1q21.1 microduplication syndrome (Table 1). Regarding the
language (dis)abilities of the affected people, the most detailed
account is Bernier et al. (4), who found that ∼10% of their
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TABLE 1 | Summary table with the most relevant clinical features of our proband
compared to other patients with the 1q21.1 microduplication syndrome [source:
Unique (https://www.rarechromo.org/), (1, 2, 4)].
Clinical features
COGNITIVE/BEHAVIORAL FEATURES
Autism or autistic behaviors
Anxiety and mood disorders x
Attention deficit-hyperactivity disorder (ADHD)
Mild-to-moderate mental retardation x
Mild-to-moderate developmental delay x
Learning disabilities x
Language disorder x
NEUROLOGICAL FINDINGS
Fine motor impairment x
Coordination disorder x
Hypotonia x
Articulatory problems/stuttering x
Seizures
Sleep disturbances x
Agility abnormalities x
PHYSICAL FEATURES
Macrocephaly (occasional craniosynostosis)
(Mild) dysmorphic facial features
Frontal bossing
Wider space between the eyebrows and above the nose
Mild hypertelorism x
Small nose x
Prominent epicanthic folds
Wide, flat nasal bridge
Low-set ears x
Stature below the average
Scoliosis
OTHER MEDICAL PROBLEMS
Gastric ulcers
Heart disease
Minor genital anomalies (hypospadias, testicles undescended at birth)
subjects suffered from language disorder, whereas phonological
processing disorder was observed in ∼ 5% of cases. Likewise,
around 10% of DECIPHER patients with a duplication within,
overlapping, or encompassing the region duplicated in our
proband (N = 224) are reported to suffer from language
problems. Nonetheless, the linguistic evaluation of patients
usually involves psychological tests only. To the best of our
knowledge, this is the first time a detailed linguistic profile of a
subject with the 1q21.1 microduplication has been provided.
Accordingly, we have conducted a fine-grained analysis of
the language strengths and weaknesses of our subject with the
1q21.1 microduplication syndrome using a battery of specific
diagnostic tools, as well as examining his language performance
in spontaneous conditions, both at the structural and the
functional levels. Overall, we found conclusive evidence of a
global delay, which plausibly results from delayed and atypical
language development in the expressive and receptive domains.
The proband’s language impairment would be on the basis of
a learning disability that precludes the normal acquisition of
executive functions and adaptive behavior, hindering the child’s
interaction with his social environment.
The expressive problems exhibited by the child seem to be
also due to altered speech processes, in the form of dysphemia
(frequent repetitions or prolongations of sounds and syllables,
as well as frequent pauses interrupting the flow of the discourse)
and dysprosody (abnormal presentation of prosodic features, like
stress, intonation, melody, or rhythmic patterns), as could be
observed during the natural spontaneous interaction between the
child and his mother. These problems might result in part from
deficient executive functions, because we have found no evidence
of pure motor speech disorders, like apraxia or dysarthria.
Finally, our proband seemingly suffers from a mild pragmatic
deficit, because of the also attested delay in the mastering
of conversational maxims [see (40, 41) for the neurotypical
population].
Regarding the molecular causes of the observed symptoms,
Dolcetti et al. (3) point out that UCSC gene expression data are
suggestive of the involvement of the genes BCL9, GJA8, PDZK1,
and PRKAB2 in the neuropsychiatric phenotype of the 1q21.1
duplication syndrome. O’Bleness et al. (6) have pointed out that
the region found duplicated in our proband contains several
candidates for human-lineage-specific neurodevelopmental
changes, including most of the genes encoding DUF1220
protein domains (NBPF10, NBPF11, NBPF12, NBPF24), as
well as PDZK1 and HYDIN2. Among the genes located within
the duplicated fragment, we have found that 2 genes have
changed their expression level in the blood of the affected subject
compared to his healthy father and his asymptomatic carrier
mother. Hence, ACP6 is significantly dowregulated, whereas
CHD1L is significantly upregulated (Figure 6).
ACP6 encodes a histidine acid phosphatase involved in
G protein-coupled receptor signaling and the balancing of
lipid composition within the cell. Interestingly, differences
in the methylation status of the gene have been correlated
with differences in hearing abilities associated to age-related
hearing impairment (42). Likewise, pathogenic variants in ACP6
have been recently identified in children with cerebral visual
impairment, which results from the impairment in projection
and/or interpretation of the visual input in the brain, and which
usually co-occurs with intellectual disability (43). The gene is
expressed at low levels in the brain (Figure 7).
Regarding CHD1L, this gene encodes a DNA helicase
protein involved in the relaxation following DNA damage and
ultimately, in DNA repair, and its overexpression has been
linked to several types of cancers (45). CHD1L is activated
by PARP1 during the initial steps of cellular reprogramming
(46, 47). Interestingly, PARP1 is one of the genes that are
differentially expressed among (mammalian) vocal learners (48),
and its product regulates as well the dyslexia-susceptibility gene
DYX1C1, important for neuronal migration in the developing
cortex (49). We didn’t find evidence of a differential expression
of PARP1 in the blood of our patient compared to his mother,
who does not exhibit speech or language problems, although
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FIGURE 3 | Chromosomal alterations and linguistic profile of the proband’s mother. (A) Screen capture of the array-CGH of the chromosome 1 of the proband’s
mother showing the microduplication at 1q21.1. (B) Developmental profile of the proband’s mother according to the verbal component of the WAIS-III (for
comparison, the figure includes the profile of the healthy, non-carrier father). The pink horizontal bar shows the normal values. (C) Reading abilities of the proband’s
mother according to the PROLEC-SE test (for comparison, the figure includes the profile of the healthy, non-carrier father: the low scores obtained by the father are
seemingly explained by his low educational level).
FIGURE 4 | DECIPHER patients of interest bearing chromosomal duplications at 1q21.1 with similar or smaller sizes than the one found in the proband. Patients with
cognitive deficits are highlighted in red, cases with no cognitive problems are highlighted in blue, whereas patients for whom no phenotypic profile is available are
highlighted in green.
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FIGURE 5 | Interaction network of the proteins coded for the most relevant genes duplicated in the proband. The network was drawn with String [version 10.5; (39)]
license-free software (http://string-db.org/), using the molecular action visualization. It includes the products of the protein-coding genes duplicated in the subject,
their potential interactors according to String, and the products of 15 strong candidates for language development/evolution. The proteins for which the expression
level of the gene was measured in the blood of the patient by qRT-PCR are framed in red (the product of the pseudogene HYDIN2 is not included in the network).
Colored nodes symbolize gene/proteins included in the query (small nodes are for proteins with unknown 3D structure, while large nodes are for those with known
structures). The color of the edges represent different kind of known protein-protein associations. Green: activation, red: inhibition, dark blue: binding, light blue:
phenotype, dark purple: catalysis, light purple: post-translational modification, black: reaction, yellow: transcriptional regulation. Edges ending in an arrow symbolize
positive effects, edges ending in a bar symbolize negative effects, whereas edges ending in a circle symbolize unspecified effects. Gray edges symbolize predicted
links based on literature search (co-mentioned in PubMed abstracts). Stronger associations between proteins are represented by thicker lines. The medium
confidence value was 0.0400 (a 40% probability that a predicted link exists between two enzymes in the same metabolic map in the KEGG database: http://www.
genome.jp/kegg/pathway.html). The diagram only represents the potential connectivity between the involved proteins, which has to be mapped onto particular
biochemical networks, signaling pathways, cellular properties, aspects of neuronal function, or cell-types of interest.
the gene is slightly upregulated in both carriers compared to
the healthy father (Supplementary Table 3). CHD1L is also a
candidate for ASD and ADHD (25, 26). Contrary to what is
observed in patients with microdeletions of the 1q21.1 region,
as the size of duplications encompassing CHD1L increases, ASD
severity also increases, whereas nonverbal IQ remains unaffected
(25). Interestingly, DECIPHER patient 285509, who bears a
microduplication affecting only to part of the gene FMO5 and the
whole sequence of CHD1L, exhibits delayed speech and language
development (Figure 3). CHD1L is highly expressed in different
brain areas, particularly in the cerebellum, where it is significantly
upregulated around birth (Figure 7). The cerebellum is involved
in almost every aspect of speech and language processing, from
syntax processing to phonological and semantic verbal fluency,
verbal working memory and speech perception and planning
(50). Moreover, it is involved as well in most of the processes that
are impaired in ASD, from language and communication to social
interaction and behavior, and cerebellar damage has been found
to contribute to the autistic phenotype (51).
We have found in the literature evidence of the potential
involvement of BCL9 in the language deficits observed in patients
with the 1q21.1 duplication syndrome. Similarly to CHD1L,
BCL9 is also highly expressed in several parts of the brain,
and particularly, in the cerebellum (Figure 7). BCL9 plays a
significant role in embryonic body axis development (52), as
part of the Wnt/β-catenin pathway (53). Specifically, BCL9
promotes transcriptional activity and nuclear retention of β-
catenin (54). β-catenin is encoded by CTNNB1, a gene related
to cognitive disorders entailing language deficits, particularly
to schizophrenia (55, 56), but also to genes that have been
hypothesized to contribute to language evolution in our species
[see (34) for details]. BCL9 itself is a candidate for schizophrenia
(27) and interacts as well with genes important for language
development and evolution. To begin with, in mice, Bcl9 is a
target of Foxp2, the renowned ‘language gene’ (57). Additionally,
BCL9 interacts with ARX to regulate canonical Wnt signaling
(58). ARX is also a target of FOXP2 (57, 59) and regulates
the migration of GABAergic interneurons (60), as well as
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FIGURE 6 | Expression profile of genes of interest in the blood of the proband. Only the genes showing significant (p < 0.05) differences with his healthy carrier
mother (A) and his healthy non-carrier father (B) are displayed. Variation in gene expression levels is expressed as fold changes.
dopaminergic neuron development (61). In humans, mutations
of ARX result in mental retardation and interneuronopathies
(62), as well as in agenesis of the corpus callosum (63),
a condition entailing deficits in problem solving and social
skills that often fall within the autistic spectrum (64, 65).
Finally, according to the Reactome Pathway Database (https://
reactome.org/), BCL9 interacts with both TLE2 and TLE3 as
part of the pathway involved in the activation and deactivation
of the β-catenin transactivating complex. Both genes encode
corepressors of gene expression and play crucial functions in
brain development (66, 67). TLE3 is a target of FOXP2 in
the inferior prefrontal cortex (68). Interestingly, we have found
that TL3 is significantly downregulated in the blood of our
proband compared to their asymptomatic parents. The gene is
upregulated in the embryonic brain, particularly, in the neocortex
(Figure 7).
Finally, among the set of robust candidates for language
disorders and language evolution, we have found that ROBO1
is strongly upregulated in the blood of our subject compared to
his healthy father and particularly, to his asymptomatic carrier
mother. ROBO1 encodes an axon guidance receptor involved
in interneuron migration and axon tract development in the
forebrain, in particular, of thalamocortical axons implicated in
diverse cognitive functions, consciousness, and alertness (69,
70). Interestingly, ROBO1 regulates interaural interaction in
auditory pathways (71), and was co-opted for vocalization in
songbirds as a component of the motor song output nucleus (72).
Overall, as part of the SLIT/ROBO pathway, ROBO1 has been
hypothesized to be a crucial candidate for speech development
and evolution [see (34) for details]. The gene is a candidate for
clinical conditions entailing speech problems, like dyslexia and
speech-sound disorder (73, 74). According to its known role in
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FIGURE 7 | Expression pattern in the body and the brain of genes of interest in the proband. (Left) Expression levels of the gene in different tissues according to the
Genotype-Tissue Expression (GTEx) project (44). Statistical analysis and data interpretation was performed by The GTEx Consortium Analysis Working Group. Data
was provided by the GTEx LDACC at The Broad Institute of MIT and Harvard. TPM, transcripts per million. (Right) Brain expression profile of the gene across
development. The expression data are from the Human Brain Transcriptome Database (http://hbatlas.org/). Six different brain regions are considered: the cerebellar
cortex (CBC), the mediodorsal nucleus of the thalamus (MD), the striatum (STR), the amygdala (AMY), the hippocampus (HIP), and 11 areas of neocortex (NCX).
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vocalization, the gene is highly expressed in several subcortical
regions (Figure 7). No DECIPHER patient bears a duplication of
ROBO1 only, so it is difficult to ascertain the effects in humans
of an excessive dosage of the gene. Nonetheless, it is interesting
that increased expression of Robo1 in rats reactivates astrocytes
after transient forebrain ischemia (75), whereas the increase of
Robo1 function in mice restores normal axon guidance in several
neuron populations (76).
In conclusion, although the exact molecular causes of the
cognitive and linguistic profile of our proband remain to be fully
elucidated, we hypothesize that his distinctive features might
result, to a large extent, from the overexpression of CHD1L.
We further hypothesize that his problems with speech might
result from subtle changes in the expression level of some of
the genes involved in the externalization of language as part of
the FOXP2/ROBO/SLIT regulatory networks, in particular, of
ROBO1, but also some of the FOXP2’s targets, like TLE2. We
wish to acknowledge two potential caveats of our study. First,
we have determined changes in the expression level of genes of
interest in the blood, whereas the phenotype under scrutiny has
a brain-based locus of impairment. Nonetheless, as shown in
Figure 7, our candidates are expressed in the blood and the brain
at similar levels. Moreover, several studies point to a significant
overlapping in gene expression patterns between both tissues,
ranging from 20% (77, 78) to 55% (79). Accordingly, we regard
that our findings in the blood can be confidently extrapolated to
the brain. Second, because the child was born following a multi-
factorial high-risk pregnancy that involved maternal diabetes
and exposure to anxiolytic drugs during embryonic and early
fetal development, we cannot rule out the possibility that these
environmental influences contributed to his language problems.
Such an effect is really difficult to estimate. Although recent
research has acknowledged diabetes as a robust predictor of
language delay in twins (80), the available literature is not fully
conclusive [see (81) for a meta-review], and in fact, most children
born from mothers with diabetes are not significantly affected if
diabetes is properly controlled during pregnancy [see (82) for
discussion]. The effect of anxiolytics is perhaps more elusive.
Considering the phenotype of our proband, it is interesting
that prenatal administration of diazepam delays the maturation
of temporal acuity in the rat auditory system (83). This effect
might result in altered speech perception in humans. However,
no association has been found between anxiolytic exposure
during pregnancy and long-term language competence (84).
Accordingly, considering as well all the evidence discussed in
the paper, we think that the language problems observed in our
proband are mostly due to the microduplication in chromosome
1. We hope our findings contribute to a better understanding of
the genetic underpinnings of human language.
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